FMP

FMP

Enter

TTOO - T2 Biosystems, Inc.

Financial Summary of T2 Biosystems, Inc.(TTOO), T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candi

photo-url-https://financialmodelingprep.com/image-stock/TTOO.png

T2 Biosystems, Inc.

TTOO

NASDAQ

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resistance to identify carbapenem resistance genes; and T2SARS-CoV-2 panel to detect SARS-CoV-2 virus. In addition, it is developing T2Biothreat for detection of biothreat pathogens; comprehensive sepsis panel to detect bloodstream infections caused by bacterial and Candida species, and antibiotic resistant markers; T2Cauris to provide direct detection of the emerging superbug Candida auris in patient skin, patient blood, and hospital environmental samples; and T2Lyme, a direct-from-blood test panel designed to run on the T2Dx Instrument to identify the bacteria that cause Lyme disease. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

5.11 USD

0.31 (6.07%)

About

ceo

Mr. John J. Sperzel III, B.Sc.

sector

Healthcare

industry

Medical - Diagnostics & Research

website

https://www.t2biosystems.com

exchange

NASDAQ

Description

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resista...

CIK

0001492674

ISIN

US89853L3024

CUSIP

89853L104

Address

101 Hartwell Avenue

Phone

781 761 4646

Country

US

Employee

113

IPO Date

Aug 7, 2014

Summary

CIK

0001492674

Exchange

NASDAQ

Industry

Medical - Diagnostic...

Sector

Healthcare

CUSIP

89853L104

ISIN

US89853L3024

Country

US

Price

5.11

Beta

0.08

Volume Avg.

335.17k

Market Cap

78.52M

Shares

-

52-Week

2.6-70.0

DCF

-0.18

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

0.05

P/B

-

Website

https://www.t2biosystems.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest TTOO News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep